Iran conflict could disrupt pharma supply chains for months and keep API prices elevated

API prices may soften slowly, not quickly

Experts warn that disruptions from the Iran conflict could take months for global pharmaceutical supply chains to stabilise. Active pharmaceutical ingredients, the key raw materials used to manufacture medicines, are expected to see only gradual relief. The delayed recovery may contribute to longer-lasting cost pressures across the medicines ecosystem, depending on how quickly routes, contracts, and inventories normalise.